259
Participants
Start Date
May 31, 2010
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
QAX576
every 3 weeks via intravenous infusion
Placebo
every 3 weeks via intravenous infusion
Novartis Investigative Site, Laken
Novartis Investigative Site, Brussels
Novartis Investigative Site, Leuven
Novartis Investigative Site, Liège
Novartis Investigative Site, Eupen
Novartis Investigative Site, Ghent
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Rüdersdorf
Novartis Investigative Site, Wheaton
Novartis Investigative Site, Großhansdorf
Novartis Investigative Site, Charleston
Novartis Investigative Site, Summerville
Novartis Investigative Site, Kassel
Novartis Investigative Site, Strakonice
Novartis Investigative Site, Owensboro
Novartis Investigative Site, Marion
Novartis Investigative Site, Mainz
Novartis Investigative Site, Minneapolis
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, St Louis
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, Huntington Beach
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Ryazan
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Samara
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, Barnaul
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, CABA
Novartis Investigative Site, Rosario
Novartis Investigative Site, Rosario
Novartis Investigative Site, Rosario
Novartis Investigative Site, Rosario
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Mendoza
Novartis Investigative Site, Santa Fe
Novartis Investigative Site, Rokycany
Novartis Investigative Site, Teplice
Novartis Investigative Site, Tábor
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Lodz
Novartis Investigative Site, Lublin
Novartis Investigative Site, Poznan
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY